Sinovac Biotech (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, has appointed China-based Ernst & Young Hua Ming LLP as its registered independent public accounting firm effective from May 14, 2013 to replace Ernst & Young LLP Canada.
On May 14, 2013, Ernst & Young LLP Canada notified the Company that it would no Reported by Benzinga.com 5 hours ago.
On May 14, 2013, Ernst & Young LLP Canada notified the Company that it would no Reported by Benzinga.com 5 hours ago.